Fortis Therapeutics rakes in $18 mln Series A

San Diego-based Fortis Therapeutics Inc, an immuno-oncology biotech company, has raised $18 million in Series A financing. Avalon Ventures led the round with participation from Bregua Corp, Lilly Asia Ventures, Osage University Partners and Vivo Capital.

North AmericaUSBriefs